NIH Research Project Grant (Parent R01 Clinical Trial Required)
ID: 357813Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357813

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-25-305.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Project Grant, designated as the Parent R01 Clinical Trial Required (Funding Opportunity Number PA-25-305). This grant supports discrete research projects that include at least one clinical trial and align with the scientific missions of participating NIH Institutes and Centers. The initiative aims to foster innovative health-related research and enhance scientific resources, with applications accepted from a diverse range of organizations, including higher education institutions and community-based organizations. Applications will open on January 5, 2025, with subsequent submission deadlines throughout 2025 and 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PA-25-305-Full-Announcement.html
    PA-25-305.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is releasing a funding opportunity for the NIH Research Project Grant, designated as the Parent R01 Clinical Trial Required (Funding Opportunity Number PA-25-305). This program supports specified projects within participating NIH Institutes and Centers (ICs) that include at least one proposed clinical trial. The primary aim is to foster innovative research that enhances health, develops scientific resources, and promotes scientific integrity. Key eligibility criteria include a focus on clinical trials, and applications are accepted from various organizations, including higher education institutions, nonprofits, and government entities. The funding is contingent on NIH appropriations, and the maximum project period is five years without specific budget limitations. Applications must comply with NIH's rigorous peer review process, considering factors such as significance, innovation, and the investigator's expertise. Key submission dates are outlined: applications open on January 5, 2025, with due dates for review cycles throughout 2025 and 2026. The opportunity underscores NIH’s commitment to advancing health-related research through the development of substantial, clinically relevant studies.
    Similar Opportunities
    NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)" aimed at supporting discrete research projects across various scientific fields, excluding clinical trials. This grant encourages applications from a diverse range of eligible entities, including higher education institutions, nonprofits, and organizations serving underrepresented communities, with the goal of fostering innovative research that enhances public health and scientific knowledge. The funding does not impose limits on application budgets, provided they reflect actual project needs, and allows for a maximum project duration of five years. Interested applicants can find more information and guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov, with the application deadline set for January 7, 2028.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) to support innovative research projects in the early stages that can lead to significant advancements in biomedical, behavioral, and clinical research. This funding opportunity requires applicants to propose at least one clinical trial and is aimed at addressing critical gaps in knowledge within the scientific missions of participating NIH Institutes and Centers. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and foreign entities, with a total project period limited to two years and a budget of up to $275,000. The application period opens on January 16, 2025, and closes on January 8, 2028; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Small Research Grant Program (Parent R03 Clinical Trial Not Allowed), aimed at supporting discrete research projects that can be completed within two years and require limited resources. This program encourages applications for various types of research, including pilot studies, feasibility studies, and the development of new research methodologies, while explicitly excluding clinical trials. With a funding ceiling of $50,000 per year, the program is open to a diverse range of eligible applicants, including higher education institutions, nonprofits, and government entities, particularly those representing historically underrepresented groups. Interested applicants should note that the first submission opportunity opens on January 16, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) to support innovative early-stage research projects that may lead to significant advancements in biomedical, behavioral, or clinical fields. This grant is designed to encourage high-risk, high-reward research, providing funding for projects that are distinct from traditional R01 grants, with a maximum budget of $275,000 over a two-year period, and no more than $200,000 in any single year. Eligible applicants include a wide range of organizations such as educational institutions, nonprofit organizations, and tribal governments, with applications undergoing a rigorous peer review process to assess their innovation and feasibility. Interested parties should note that the application submission period begins on January 16, 2025, with the opportunity closing on January 7, 2028; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for small Research Project Grants (R01s) aimed at clinical trials focused on diseases under the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative encourages the submission of pilot and feasibility clinical trials that will provide foundational data for larger, definitive trials intended to improve the prevention and treatment of various health conditions, without the requirement of preliminary efficacy data. The program supports innovative research ideas and emphasizes equitable recruitment from diverse populations, with a maximum grant duration of three years and funding up to $200,000 per year. Interested applicants can find more information and submit their applications by May 7, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required), inviting applications for long-term clinical trials lasting 6 or 7 years. These trials must be hypothesis-driven, aligned with NIH's research mission, and include clearly defined objectives and milestone planning to monitor progress. This initiative emphasizes the importance of extended clinical trials in advancing critical biomedical research, with no specific budget limits but requiring justification based on project needs. Interested applicants must consult with NIH staff prior to submission, adhere to new application forms and data sharing policies, and submit their applications by January 13, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-084.html.
    Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a funding opportunity for small R01 grants aimed at supporting clinical trials that address diseases within its mission. This initiative encourages pilot and feasibility studies in human subjects to gather preliminary and feasibility data necessary for larger clinical trials focused on the prevention and treatment of diabetes and other related conditions. With an anticipated budget of $1 million for fiscal year 2025, NIDDK plans to fund up to three awards, each with a maximum direct cost of $200,000 annually over a three-year project period. Interested applicants must submit their proposals electronically through Grants.gov by May 7, 2026, and are encouraged to include a "Plan for Enhancing Diverse Perspectives" to promote inclusivity in their research efforts. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) to support innovative basic experimental studies involving human participants. This funding opportunity aims to foster research that enhances health outcomes and economic well-being, specifically targeting studies that prospectively assign human participants to conditions to assess biomedical or behavioral outcomes. Eligible applicants include a wide range of institutions, such as historically black colleges, tribal colleges, and foreign organizations, with no cost-sharing requirements. Interested parties should note that applications are due by January 7, 2028, and must comply with registration requirements in SAM and eRA Commons. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-25-303.html.
    NICHD Small Research Grant Program (R03 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03 Clinical Trial Required) to support clinical trials aligned with the mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This program aims to fund small-scale research projects, including pilot studies and methodological development, with a maximum budget of $50,000 per year for up to two years. The funding is crucial for advancing knowledge in human development fields, particularly in childhood development and rehabilitation medicine. Interested applicants must adhere to specific guidelines and register with Grants.gov and eRA Commons, with the application window opening on January 16, 2025, and closing on January 8, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a funding opportunity for Single-Site Investigator-Initiated Clinical Trials (R61/R33), aimed at supporting applications for clinical trials that test therapeutic, behavioral, or prevention strategies relevant to NHLBI's mission. This funding mechanism involves a bi-phasic award structure, with an initial R61 phase focused on protocol development followed by an R33 phase for trial execution, emphasizing comprehensive project management, subject recruitment, and community engagement. The initiative is particularly significant for advancing clinical research while promoting diversity among study participants and project teams. Interested applicants can find more details and submit proposals by September 12, 2025, and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.